Close Menu

The Scan

A bill to increase federal funding for embryonic stem cell research could reappear tomorrow in the US House of Representatives. Assuming it passes, Hill watchers say there may be enough votes to override a veto from President Bush.

A roundup of three papers in the current Nature Biotechnology.

Faculty of $1,000

Nature Genetics sees its chance to hop on the $1,000 genome bandwagon as experts weigh in on pie-in-the-sky sequencing plans.

The Buffalome?

Today's Science Times reports on a conservation genetics push to keep bison home on the range.

A profile of Craig Venter and his synthetic biology aspirations in The Atlantic Monthly may not do much for one scientist's modesty.

In this video, Sanger's Tim Hubbard presents the challenges of working with and keeping up with genomic data to the folks at Google.

Wired magazine ranks the top 10 cities where tech geeks rule the roost.

George Johnson reviews Freeman Dyson's latest book, a collection of essays from one of the translational pioneers in physics.

This week's issue of Newsweek includes a short profile of Thermal Gradient's high-speed DNA amplification technology.

Taking on H5N1

A DNA-based vaccine for avian flu enters human trials, NIH says.

Today's issue of Science offers papers involving microRNAs and microfluidics, as well as a letter reflecting on a pattern in Nobel Prize awards.

This article from The Economist proves that for humans, like hot dogs, sometimes it's best not to know what's inside.

No Judgment Here

Nature's first issue of the new year doesn't disappoint.

Boise State researchers are seeking out DNA sequences that would be so threatening to life they actually don't exist in nature.

Retractions galore in the community, from the Taiwan team accused of image manipulation to the series of papers that featured incorrect data thanks to faulty software.

Mainstream media is picking up on the looming threat to the otherwise-promising personalized medicine: getting insurers to fork over the money.

NAR's Database Issue is out, and its editorial offers good practice advice for building a better repository.

The annual Darwin Awards release their winners for 2006. Their raison d'etre: "the improvement of the human genome by honoring those who accidentally remove themselves from it."

All Eyes on Imaging

New imaging procedures published in CSH Protocols.

Discover magazine joins the publications taking a swing at the "best of 2006" lists with the top genetics stories as well as the top scientist of the year.

Bioinformaticists, rejoice: industry watchers are already spreading doubt about Microsoft's long-awaited Vista platform. How much do we love Linux? Let us count the ways.

Cold Case, CDC Style

A group within the US Centers for Disease Control tackles what others have deemed impossible, trying to elicit causes for unexplained deaths in cases that may be linked to pathogens or emerging infectious diseases.

Years after President Bush's stem cell decision, scientists are still struggling to comply with the rules while finding ways to advance their research.

An 'omics blogger gives a positive review to the Field Museum's Mendel exhibit.

Genetics and Health blogger prepares for the inevitable after the latest news out of Britain's National DNA Database.


The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.